ADMA ADMA BiologicsWatchlist
About ADMA Biologics Company
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
ADMA, ALLK and NRIX Are Among After Hour Movers
Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Insider Buy: Adma Biologics
Jerrold B Grossman, Director, on August 30, 2023, executed a purchase for 130,000 shares in Adma Biologics (ADMA) for $482,144. Following the Form 4 filing with the SEC, Grossman has control over a to
- $Consolidated Communications(CNSL.US)$ +14.6%: Searchlight affirms 34.6% active holding; to evaluate the possibility of a further investment in or full acquisition.
- $Voyager Therapeutics(VYGR.US)$ +12.2%: agrees to licensing option with $Novartis AG(NVS.US)$; Voyager receives $54 million upfront.
- $Aegon NV(AEG.US)$ +6%: provides update on Russian and Belarusian investments following invasion of Ukraine.
- $AZZ Inc(AZZ.US)$ +...